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Role of Pharmacist to Overcome the
Challenges related to COVID-19 Vaccines
Dr. Faqeeha Shakeel, Pharmacist
Grappling
with
l Availability, assessability and appeal of immunization
Convenience
the third wave of
services affect vaccine acceptance
COVID-19 will not
l In terms of efficacy and safety, what is patient’s level
be easy. To overcome
Confidence
of interest
the
challenges
against this outbreak Complacency l Vaccine is not considered as essential part of
preventive disease or to lower the risk
certain steps have
been taken and one of the steps is inoculation of the COVID-19 vaccines to
develop herd immunity. Vaccines are considered to be one of the most costeffective means of preventing illness and death from certain outbreaks just like
COVID-19. Since, recent approvals of COVID-19 Vaccine there are a lot of
individuals who are reluctant to get vaccinated despite the availability of safe
and effective vaccines. As per WHO vaccine hesitancy was rated among the top
10 threats to global health.
Here, the role
Approved COVID-19 vaccines in Pakistan
of
Pharmacist
begins
because
Pfizerpharmacists are Sinopharm CanSino Sputnik V Sinovac AstraZeneca BioNTech
(2 Doses; 21
(Single
(2 Doses; 21 (2 Doses; 28 (2 Doses; 12
well
positioned
(2 Doses; 21
Days Apart)
Dose)
Days Apart) Days Apart) Weeks Apart) Days Apart)
to
improve
vaccination rates
as they can act as patient educator, advocate, identifier, and immunizer as well.
Vaccine hesitancy is being influenced by 3Cs which are complacency, convenience
and confidence. And other than that different barriers can aggravate the vaccine
denial which are lack of awareness, insufficient or misinformation about vaccine
and believing on myths and various misconceptions.
What pharmacist can do to overcome challenges??
•
•
•
•
•
l

Find out public fear and counsel the public about safety and efficacy of
vaccine (e.g. it’s an inactivated virus it won’t harm you)
Listen to public, acknowledge their concerns and make them feel at ease.
Let public know how vaccine works and how immune system responds
Counsel public how it can prevent from outbreak, if it cannot show 100
percent efficacy but has the ability to reduce severity of disease.
Share personal experience of vaccine with them to enhance level of trust.
Answer public questions and give recommendation accordingly.

Reference:
Chronic Therapy Medications During
the Perioperative Period: To Continue
or Discontinue?.....................................Page 4

Virginia YCT BS Pharm, RPh Clinical Pharmacist/Freelance Medical Writer Haymarket. The Role of the
Pharmacist in Overcoming Vaccine Hesitancy [Internet]. [cited 2021 May 4]. Available from: https://www.
uspharmacist.com/article/the-role-of-the-pharmacist-in-overcoming-vaccine-hesitancy
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How to get vaccinated from AKUH?
Step 1:
Send your CNIC number to 1166.
Step 2:
Verification Code received along
with Vaccination Date and Center.
AKUH Employees/Students:

General Public:

Walk in at our designated
vaccination center.

Take appointment by dialing
AKUH Helpline Number.

Myths & Facts about COVID-19 Vaccine
Dr. M. Umair Ihsan, Pharmacist

Myths

Facts

COVID-19 vaccine can
make me sick with
COVID-19

Authorized and recommended COVID-19 vaccines contain
killed viruses which cannot make you sick with COVID-19.

I have already
had COVID-19 and
recovered, I don’t need
to get vaccinated with a
COVID-19 vaccine.

You should be vaccinated regardless of whether you already
had COVID-19. That’s because experts do not yet know how
long you are protected from getting sick again (reinfection)
after recovering from COVID-19.

COVID-19 vaccine will
alter my DNA.

The mRNA from a COVID-19 vaccine never enters the
nucleus of the cell. Hence, cannot alter DNA.

COVID-19 vaccine has
a potential to cause
infertility

There is currently no evidence that COVID-19 vaccination
causes any problems with fertility, including the development
of the placenta and fetus.

I Can not breastfeed
my baby after getting
COVID-19 vaccination

There is currently no evidence that COVID-19 vaccination
causes any problems with breastfeeding. Some experts prefer
to get vaccinated so that the baby can also develop immunity
against COVID-19.

Reference:
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/facts.html
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Medication Loss in the Tubing while Administration
Dr. Mehreen Muzammil, Clinical Pharmacist
Every year Institute for Safe Medication Practices (ISMP) declare top 10 medication errors reported from every part
of the world. With that, precautions to decrease the incidence of error are also suggested. The list depends on the errors
which have serious consequences to the patient and can be prevented. One of the error identified in these top 10 error was
“Medication loss in the tubing when administering small-volume infusions via a primary administration set”
Small volume of infusions i.e. 50ml to 100ml (of antibiotics) are administered by long administration set connected to
patients’ vascular access. This can result in under dosing because the residual volume in administration set may not be
administered to patient. Primary administration set will have residual volume of around 25 ml. In order to reduce the
harm, recommendation is to administer little secondary infusion and flush the residual volume through the drip set to
confirm that the patient received the total medication dose.
Lack of awareness among nurses, pharmacists and prescribers reported this error globally. There is need to consider that
remaining 25ml solution of antibiotic lead to under dosing may result in patient’s bad outcome, infection may remain
untreated. Under dosing has clinical impact, in sepsis, patient will result in low antibiotic levels and less time with
minimum inhibitory concentration. Same when patient being administered anti-epileptics like levetiracetam blood levels
will be low and time to reach the effective therapeutic concentration in blood will be longer.
Reference:
Harding M, Stefka S, Bailey M, Morgan D, Anderson A. Best practice for delivering small-volume intermittent intravenous infusions. J Infus Nurs. 2020;43(1):47-52.

One Pill can kill | Advancing your knowledge of Paediatric Toxicology
Dr. Hafsah Ashfaq, Clinical Pharmacist
Children are the victims in 68% of all poisoning exposures. Most of the reported exposures involve Toddlers (1-4 Years
of age). Kids are curious and they keep on putting things in their mouths. Exploring what objects feel and taste like is part
of their curiosity. It is important to be aware of the toxic potential of medications that are at home, and to keep them out
of the reach of children.
Few medications that can be harmful if only a small amount (1-2 tablets) is ingested for a 15 kg less child.
Drug

Potentially
Fatal Dose
(mg/kg)

Toxicity

Signs/ Symptoms of Toxicity

Calcium Channel
Blockers

15

Myocardial suppression

PR Prolongation, Bradydysrhythmias, Hypotension, CHF

Tricyclic
Antidepressants

15

Na+ channel blockade, alpha 1
blockade

Coma, Seizures, Tachycardia followed by Hypotension and
Bradydysrhythmias

Antimalarials

20

Na+ channel blockade, direct
retinal damage

Prolonged QRS/QT, Torsades, Hypotension, Tinnitus,
Vision Loss, Headache, Vertigo, Seizures

Sulfonylureas

0.1

Activates insulin release

Hypoglycemia, Irritability, Lethargy, Seizures and Coma

Codeine

10

Respiratory depression

Miosis, CNS Depression, Hypopnea

Class 1 Antiarrhythmics

25

Na+ channel blockade

Prolonged PR/QRS, QT (Class 1A Agents),
Headache, Nausea/Vomiting
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Chronic Therapy Medications During the Perioperative Period: To
Continue or Discontinue?
Dr. Fariha Ayaz, Pharmacist
Long term medication therapy for chronic conditions is often necessary to maintain the patient’s physiological condition.
The decision to withhold such therapy is made by the physician/anaesthetist guided by the pharmacist in both inpatient &
outpatient setups whilst counselling a patient prior to surgery. This depends on the patient’s current medical condition and
the potential for withdrawal symptoms, worsening of patient’s underlying physiological condition, drug interaction with
aesthetic medications, perioperative hemodynamic instability or postoperative complications such as bleeding.
ADMINISTRATION OF CHRONIC MEDICATIONS PRIOR TO SURGERY
Drug Classification

Discontinued/Continued

Rationale/Consequences

Beta Blockers

Continue in patients with ACC/AHA Class I guideline
indications (Angina, symptomatic arrhythmia, postMI)

Abrupt discontinuation when on chronic
therapy increases risk of death intraoperative &
postoperatively.

ACEIs/ARBs

Withhold 24 hours before surgery when indicated
(Adverse post-op effects i.e. rebound hypertension &
atrial fibrillation)

Increase risk of hypotension after induction of
anaesthesia which is not controlled by conventional
vasopressors (only by vasopressin).

Statins

Continued.

Preoperative withdrawal in patients undergoing
major vascular surgery increases risk of MI and
cardiovascular death postoperatively.

Diuretics

Held the morning of surgery.

To minimize risk of hypovolemia & electrolyte
abnormalities.

Oral Antidiabetic Agents

Held the morning of surgery and not restarted until
food intake resumes.

To reduce risk of hypoglycaemia.

In renal dysfunction/IV contrast media:

To reduce risk of perioperative lactic acidosis.

Metformin discontinued 24-48 hours prior to surgery.
Antiepileptic, Carbidopa/
Levodopa, Antipsychotic,
BZDs, SSRIs, SNRIs,
TCAs.

Continue up to and including the morning of surgery.

Greater risk of withdrawal or disease decompensation
than for perioperative complications.

Corticosteroids

Continuation of normal dose (Supplemental doses
required in Addison’s disease)

Patients generally able to increase their endogenous
adrenal function above their baseline dose to meet
increased demands of surgery.

Reference:
Koda Kimble & Young’s Applied Therapeutics Tenth Edition
https://pubmed.ncbi.nlm.nih.gov/9563428/

Provide us your Valuable Feedback!
To keep the Pharmacy Newsletter of Aga Khan University Hospital (AKUH) updated we would like to take your valuable feedback. We are grateful
to you for sparing few minutes of your precious time to complete form by below online link or form can be emailed to you as well. Just drop us an
email with subject Newsletter Feedback. Email us at:drug.information@aku.edu
For Formulary supplements assistance visit http://portal.aku.edu/pharmacy/olf.asp or Call 34861504/1506
Thank you in advance for your feedback! Link: https://forms.gle/FCo9ZuE4CConzFp46
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